BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 27655131)

  • 21. Involvement of the Gap Junction Protein, Connexin43, in the Formation and Function of Invadopodia in the Human U251 Glioblastoma Cell Line.
    Chepied A; Daoud-Omar Z; Meunier-Balandre AC; Laird DW; Mesnil M; Defamie N
    Cells; 2020 Jan; 9(1):. PubMed ID: 31947771
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PREX1 integrates G protein-coupled receptor and phosphoinositide 3-kinase signaling to promote glioblastoma invasion.
    Gont A; Daneshmand M; Woulfe J; Lavictoire SJ; Lorimer IA
    Oncotarget; 2017 Jan; 8(5):8559-8573. PubMed ID: 28051998
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A RhoG-mediated signaling pathway that modulates invadopodia dynamics in breast cancer cells.
    Goicoechea SM; Zinn A; Awadia SS; Snyder K; Garcia-Mata R
    J Cell Sci; 2017 Mar; 130(6):1064-1077. PubMed ID: 28202690
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An Experimenter's Guide to Glioblastoma Invasion Pathways.
    de Gooijer MC; Guillén Navarro M; Bernards R; Wurdinger T; van Tellingen O
    Trends Mol Med; 2018 Sep; 24(9):763-780. PubMed ID: 30072121
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 5'-Inositol phosphatase SHIP2 recruits Mena to stabilize invadopodia for cancer cell invasion.
    Rajadurai CV; Havrylov S; Coelho PP; Ratcliffe CD; Zaoui K; Huang BH; Monast A; Chughtai N; Sangwan V; Gertler FB; Siegel PM; Park M
    J Cell Biol; 2016 Sep; 214(6):719-34. PubMed ID: 27597754
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oct-3/4 promotes migration and invasion of glioblastoma cells.
    Kobayashi K; Takahashi H; Inoue A; Harada H; Toshimori S; Kobayashi Y; Goto K; Sugimoto K; Yano H; Ohnishi T; Tanaka J
    J Cell Biochem; 2012 Feb; 113(2):508-17. PubMed ID: 21938739
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of extracellular matrix and microenvironment in regulation of tumor growth and LAR-mediated invasion in glioblastoma.
    Kim Y; Kang H; Powathil G; Kim H; Trucu D; Lee W; Lawler S; Chaplain M
    PLoS One; 2018; 13(10):e0204865. PubMed ID: 30286133
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ezrin regulates focal adhesion and invadopodia dynamics by altering calpain activity to promote breast cancer cell invasion.
    Hoskin V; Szeto A; Ghaffari A; Greer PA; Côté GP; Elliott BE
    Mol Biol Cell; 2015 Oct; 26(19):3464-79. PubMed ID: 26246600
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CRP2, a new invadopodia actin bundling factor critically promotes breast cancer cell invasion and metastasis.
    Hoffmann C; Mao X; Dieterle M; Moreau F; Al Absi A; Steinmetz A; Oudin A; Berchem G; Janji B; Thomas C
    Oncotarget; 2016 Mar; 7(12):13688-705. PubMed ID: 26883198
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glioblastoma stem cells exploit the αvβ8 integrin-TGFβ1 signaling axis to drive tumor initiation and progression.
    Guerrero PA; Tchaicha JH; Chen Z; Morales JE; McCarty N; Wang Q; Sulman EP; Fuller G; Lang FF; Rao G; McCarty JH
    Oncogene; 2017 Nov; 36(47):6568-6580. PubMed ID: 28783169
    [TBL] [Abstract][Full Text] [Related]  

  • 31. NEDD9 regulates 3D migratory activity independent of the Rac1 morphology switch in glioma and neuroblastoma.
    Zhong J; Bach CT; Shum MS; O'Neill GM
    Mol Cancer Res; 2014 Feb; 12(2):264-73. PubMed ID: 24337070
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumor microenvironment tenascin-C promotes glioblastoma invasion and negatively regulates tumor proliferation.
    Xia S; Lal B; Tung B; Wang S; Goodwin CR; Laterra J
    Neuro Oncol; 2016 Apr; 18(4):507-17. PubMed ID: 26320116
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hic-5 regulates Src-induced invadopodia rosette formation and organization.
    Gulvady AC; Forsythe IJ; Turner CE
    Mol Biol Cell; 2019 May; 30(11):1298-1313. PubMed ID: 30893012
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A role for activated Cdc42 in glioblastoma multiforme invasion.
    Okura H; Golbourn BJ; Shahzad U; Agnihotri S; Sabha N; Krieger JR; Figueiredo CA; Chalil A; Landon-Brace N; Riemenschneider A; Arai H; Smith CA; Xu S; Kaluz S; Marcus AI; Van Meir EG; Rutka JT
    Oncotarget; 2016 Aug; 7(35):56958-56975. PubMed ID: 27486972
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TROY (TNFRSF19) is overexpressed in advanced glial tumors and promotes glioblastoma cell invasion via Pyk2-Rac1 signaling.
    Paulino VM; Yang Z; Kloss J; Ennis MJ; Armstrong BA; Loftus JC; Tran NL
    Mol Cancer Res; 2010 Nov; 8(11):1558-67. PubMed ID: 20881009
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CD151-α3β1 integrin complexes are prognostic markers of glioblastoma and cooperate with EGFR to drive tumor cell motility and invasion.
    Zhou P; Erfani S; Liu Z; Jia C; Chen Y; Xu B; Deng X; Alfáro JE; Chen L; Napier D; Lu M; Huang JA; Liu C; Thibault O; Segal R; Zhou BP; Kyprianou N; Horbinski C; Yang XH
    Oncotarget; 2015 Oct; 6(30):29675-93. PubMed ID: 26377974
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anosmin-1 contributes to brain tumor malignancy through integrin signal pathways.
    Choy CT; Kim H; Lee JY; Williams DM; Palethorpe D; Fellows G; Wright AJ; Laing K; Bridges LR; Howe FA; Kim SH
    Endocr Relat Cancer; 2014 Feb; 21(1):85-99. PubMed ID: 24189182
    [TBL] [Abstract][Full Text] [Related]  

  • 38. β3 integrin expression is required for invadopodia-mediated ECM degradation in lung carcinoma cells.
    Peláez R; Morales X; Salvo E; Garasa S; Ortiz de Solórzano C; Martínez A; Larrayoz IM; Rouzaut A
    PLoS One; 2017; 12(8):e0181579. PubMed ID: 28767724
    [TBL] [Abstract][Full Text] [Related]  

  • 39. IL-6 promotion of glioblastoma cell invasion and angiogenesis in U251 and T98G cell lines.
    Liu Q; Li G; Li R; Shen J; He Q; Deng L; Zhang C; Zhang J
    J Neurooncol; 2010 Nov; 100(2):165-76. PubMed ID: 20361349
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comprehensive proteome profiling of glioblastoma-derived extracellular vesicles identifies markers for more aggressive disease.
    Mallawaaratchy DM; Hallal S; Russell B; Ly L; Ebrahimkhani S; Wei H; Christopherson RI; Buckland ME; Kaufman KL
    J Neurooncol; 2017 Jan; 131(2):233-244. PubMed ID: 27770278
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.